A Phase II study of iodine-131 tositumomab plus chemotherapy in patients with previously untreated mantle cell lymphoma

Saved in:

Bibliographic Details
Published in	Clinical lymphoma, myeloma and leukemia Vol. 20; no. 11; pp. 749 - 756.e1
Main Authors	Zelenetz, Andrew D., Popplewell, Leslie L., Noy, Ariela, Horner, Thierry J., Lin, Thomas S., Donnelly, Gerard, Sgouros, George, Rijo, Ivelise, Divgi, Chaitanya R.
Format	Journal Article
Language	English
Published	29.04.2019
Online Access	Get full text

Loading…

More Information
Bibliography:	ADZ was the Principle Investigator, designed the study and protocol, contributed to data collection, analysis and interpretation. AN, CRD, GS, GD, IR, and LLP contributed to protocol development and data acquisition. TJH, and TSL contributed to the study design and data analysis and interpretation. All authors were involved at each stage of manuscript preparation and approved the final version. Current affiliation: Janssen, Scientific Affairs, Horsham, PA, USA Current affiliation: NYU Perlmutter Cancer Center, Lake Success, NY, USA Author contributions
ISSN:	2152-2650 2152-2669
DOI:	10.1016/j.clml.2019.04.010